why choose us

First received: June 02, 2023

Clinical Trial: Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Crohn Disease

Study Type: INTERVENTIONAL


Official Title: Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Brief Summary: Post-marketing registration of Infliximab for injection in Chinese pediatric Crohn's disease patients.

Read more